30 Day FDA and ICH Drug Development Regulations - Day 22 Post-Marketing Surveillance

Discover the fascinating world of post-marketing surveillance in this episode, where we explore how the journey of a drug continues long after it hits the market. Learn how pharmacovigilance, adverse event reporting, and risk management plans ensure ongoing safety and effectiveness in the real world. Dive into the critical roles of observational studies, Phase IV trials, and groundbreaking laws like PREA that push for pediatric-specific research. Uncover the ethical balance between data collection and patient autonomy, and see how this ever-evolving process keeps patients safe while uncovering new treatment possibilities. Join us for an eye-opening journey into the science, ethics, and future of drug safety.